November 25, 2024

Effect of past extensive ulcers on fecal calprotectin in ulcerative colitis – BMC Gastroenterology

November 25, 2024

Palatin Completes Phase 2 Enrollment for Novel Ulcerative Colitis Pill, Data Due Q1 2025 | PTN Stock News – StockTitan

November 25, 2024

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis – Morningstar

November 22, 2024

How to Sleep Better With Ulcerative Colitis – Health Central

November 22, 2024

Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor – PR Newswire